2026 CARRA-Arthritis Foundation Advancing Biosample Collection Award
Funds biosample collection at CARRA sites to support translational research in pediatric rheumatic diseases, emphasizing precision medicine and critical research priorities.
Funder: Childhood Arthritis and Rheumatology Research Alliance
Due Dates (Anticipated): January 2027: Letter of Intent | January 2027: Data and Sample Share Request | March 2027: Full Application
Funding Amounts: Up to $50,000 per award for a 2-year project; typically 2 awards per cycle (at least 1 for JIA).
Summary: Supports biosample collection at CARRA Registry sites to advance translational research in pediatric rheumatic diseases, with emphasis on precision medicine and critical research priorities.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
Description
This grant supports the collection of biosamples from patients enrolled in the CARRA Registry to enable hypothesis-driven, translational research in pediatric rheumatic diseases. The program funds biosample collection at CARRA Registry sites using standardized kits, ensuring high-quality and comparable samples for future research. Projects must align with the 2023–2025 CARRA-Arthritis Foundation Inflammatory Arthritis Research Agenda, with priority given to topics such as precision medicine, biomarker identification, medication impact, genetic and environmental influences, long-term outcomes, health disparities, and treatment safety. Collected samples are stored in designated biobanks and made available for future research within the CARRA network.
